Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gilbert Ross

Showing results (31-40 of 38) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 38 results.
Cancer Research|August 29, 2024
Live-Cell Invasive Phenotyping Uncovers ALK2 as a Therapeutic Target in LKB1-Mutant Lung CancerJunghui Koo, Chang-Soo Seong, Rebecca E Parker, et al.
Iscience|November 11, 2024
Intra-tumoral YAP and TAZ heterogeneity drives collective NSCLC invasion that is targeted by SUMOylation inhibitor TAK-981Richa Sharma, Shagun Sharma, Pratik Shriwas, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|November 28, 2020
YAP1 Expression in SCLC Defines a Distinct Subtype With T-cell-Inflamed PhenotypeTaofeek K Owonikoko, Bhakti Dwivedi, Zhengjia Chen, et al.
Nature Communications|April 12, 2025
Nanoparticle delivery of a prodrug-activating bacterial enzyme leads to anti-tumor responsesSebastian G Huayamares, Liming Lian, Regina Rab, et al.
Cancer Research|April 7, 2017
Modulation of Bax and mTOR for Cancer TherapeuticsRui Li, Chunyong Ding, Jun Zhang, et al.
JCI Insight|March 15, 2017
Targeting adhesion signaling in <i>KRAS, LKB1</i> mutant lung adenocarcinomaMelissa Gilbert-Ross, Jessica Konen, Junghui Koo, et al.
Biorxiv : the Preprint Server for Biology|September 30, 2024
Tenascin-C in the early lung cancer tumor microenvironment promotes progression through integrin αvβ1 and FAKShiela C Samson, Anthony Rojas, Rebecca G Zitnay, et al.
Biorxiv : the Preprint Server for Biology|February 7, 2023
Loss of the endocytic tumor suppressor HD-PTP phenocopies LKB1 and promotes RAS-driven oncogenesisChang-Soo Seong, Chunzi Huang, Austin C Boese, et al.
Pageof 4

Showing results (31-40 of 38) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 38 results.
Cancer Research|August 29, 2024
Live-Cell Invasive Phenotyping Uncovers ALK2 as a Therapeutic Target in LKB1-Mutant Lung CancerJunghui Koo, Chang-Soo Seong, Rebecca E Parker, et al.
Iscience|November 11, 2024
Intra-tumoral YAP and TAZ heterogeneity drives collective NSCLC invasion that is targeted by SUMOylation inhibitor TAK-981Richa Sharma, Shagun Sharma, Pratik Shriwas, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|November 28, 2020
YAP1 Expression in SCLC Defines a Distinct Subtype With T-cell-Inflamed PhenotypeTaofeek K Owonikoko, Bhakti Dwivedi, Zhengjia Chen, et al.
Nature Communications|April 12, 2025
Nanoparticle delivery of a prodrug-activating bacterial enzyme leads to anti-tumor responsesSebastian G Huayamares, Liming Lian, Regina Rab, et al.
Cancer Research|April 7, 2017
Modulation of Bax and mTOR for Cancer TherapeuticsRui Li, Chunyong Ding, Jun Zhang, et al.
JCI Insight|March 15, 2017
Targeting adhesion signaling in <i>KRAS, LKB1</i> mutant lung adenocarcinomaMelissa Gilbert-Ross, Jessica Konen, Junghui Koo, et al.
Biorxiv : the Preprint Server for Biology|September 30, 2024
Tenascin-C in the early lung cancer tumor microenvironment promotes progression through integrin αvβ1 and FAKShiela C Samson, Anthony Rojas, Rebecca G Zitnay, et al.
Biorxiv : the Preprint Server for Biology|February 7, 2023
Loss of the endocytic tumor suppressor HD-PTP phenocopies LKB1 and promotes RAS-driven oncogenesisChang-Soo Seong, Chunzi Huang, Austin C Boese, et al.
Pageof 4